Thank you for submitting your manuscript for consideration by The EMBO Journal, and please accept my apologies for the fact that it has taken us somewhat longer than usual to evaluate it. We have now received the reports of three referees, with the comments directly to the authors attached below. While two of these reviewers find your study interesting in principle and would therefore support publication pending satisfactory revision of a number of major issues, referee 2 is less positive with regard to the novel insight and overall advance presented by the study, partially due to the fact that the too selective citation of previous work may have failed to properly put the study into the context of existing knowledge on the topic. Given the positive assessment by two of the referees and the overall interest and importance of the topic, I nevertheless feel that we should be able to consider a revised manuscript for publication if you should be able to adequately address the main issues raised by the referees. This should include more specific issues such as essential controls (e.g. for the RNAi knockdown approaches), better experimental descriptions as well as extension to more physiologically relevant cell types such as primary MEFs. In addition, the referees also point out both internal inconsistencies and contradictions with regard to published evidence, which would need to be satisfactorily reconciled. Finally, I would like to urge you for a more complete citation of (and discussion in the light of) previous and related work (in addition to the examples mentioned by referee 2, I noticed at least some additional selective omissions), reminding you that the new editorial policy of The EMBO Journal puts no more restrictions on the number of citations, with the bibliography no longer included in the total character count.
Please also keep in mind that it is EMBO Journal policy to allow a single round of major revision only, and that it is therefore essential that you diligently answer to all the points raised at this stage if you wish the manuscript ultimately to be accepted. In any case, please do not hesitate to get back to us should you need feedback on any issue regarding your revision.
Thank you for the opportunity to consider your work for publication. I look forward to your revision. In this manuscript the authors show that the transcription factor FoxM1 is induced by increased intracellular ROS. They further show that upregulated FoxM1 counteracts elevated intracellular ROS levels to protect dividing cells including tumor cells from oxidative stress. The authors further claim that tumor cells which express high Akt levels or activity, which leads to increased ROS, may be addicted to FoxM1. This is an interesting model.
The link between ROS and upregulation of FoxM1 is unclear. The authors show that H2O2 upregulates FoxM1 and catalase blocks this, suggesting that hydrogen peroxide is important for gene induction. However, MnSOD mimetics (which generate hydrogen peroxide) inhibit the gene induction, while a MnSOD inhibitor induces FoxM1 gene induction. Isn't this contradictory? Which one of these reactive oxygen species is the important now? This needs to be clarified.
In Fig. 1B and Suppl. The stable cell lines used in several figures: are these clonal selections? If yes, several clones should be shown.
In Fig. 2B and Fig. 3 : Can the siRNA effects be rescued by expression of FoxM1 (of another species)? This would be important to rule out off-target effects. Alternatively a second independent siRNA targeting FoxM1 could be used. Effects of the siRNA on other Fox transcription factors should be tested to rule out off-target effects. In Fig. 2B , control bots for the knockdown of FoxM1 should be included. In this manuscript, the authors bridged two independent events during malignant proliferation of tumor cells, the regulations of FoxM1 and ROS in cell proliferation/viability. The authors also addressed the question whether Foxm1 is essential for protecting cells from oxidative stress and senescence. However, these concepts are not novel, as they have been described by Li et al in the Journal of Biological Chemistry on June, 2008 (actually that manuscript was received for publication on November, 2007). In addition, Delpuech et al (MCB, 2007) reported that FoxM1 is a downstream target of FoxO3a-mediated repression of cell proliferation through the PI3K/Akt signaling pathway. Unfortunately, the authors of the current manuscript did not mention the above two studies at all. The novel part of this study is that the authors describe a negative feedback loop for FoxM1 in regulating ROS in proliferating cells by identifying MnSOD and catalase as direct targets of FoxM1. However, MnSOD and catalase are also known FoxO3a targets. Thus, these major issues must be addressed before the manuscript can justify the interpretations made by the authors.
Another major issue of this manuscript is that the methods are poorly described in the Method section, though some appeared partially in the figure legends. This makes it very difficult to evaluate all figures and results appropriately. For example: 1. Fig. 1D and E: what cells were used? 2. This manuscript describes the regulation of FoxM1 expression by oncogene-induced oxidative stress. The authors show that expression of activated Ras in immortalised mouse embryonic fibroblasts (MEFs) causes increased ROS production and that inhibition of ROS prevents induction of FoxM1 expression in these cells. They also show that FoxM1 is required for V12 Ras expression MEFs for efficient colony formation in soft agar and that silencing of FoxM1 increases acidic betagal staining in Ras-ER expressing human embryonic lung fibroblasts (IMR90). Furthermore, the authors show that cells depleted of FoxM1 show activation of p38 and that senescence induced by FoxM1 depletion is sensitive to a p38 inhibitor. In addition, depletion of FoxM1 increase p38 activation and senescence in response to peroxide treatment and expression of a constitutively active mutant of FoxM1 decreases activation of p38 and increases survival in the presence of peroxide. The authors investigate next whether FoxM1 participates in the detoxification of cellular ROS levels. Silencing of FoxM1 increases cellular ROS as shown by DCF-fluorescence (indicator of cellular ROS) and DHE-fluorescence (indicator of superoxide). Silencing of FoxM1 results in decreased mRNA expression of the ROS detoxifying enzymes catalase, PRDX3 and MnSOD. The authors also identified binding of FoxM1 to the promoter regions of catalase and MnSOD. The authors also investigate whether FoxM1 expression is essential for oncogene expressing cells. IMR90 fibroblasts expressing an inducible version of Akt show a small increase in ROS levels upon Akt activation, which is prevented by co-expression of FoxM1. Furthermore, induction of acidic beta-gal staining in response to Akt activation is reduced by FoxM1 over-expression and FoxM1 expression increases Akt-induced soft-agar growth in immortalised MEFs. Silencing of FoxM1 causes an increase in acidic beta-gal staining and irreversible growth arrest in U2OS cells expressing active Akt. Thus, the authors conclude that FoxM1 is required to relieve production of reactive oxygen species and therefore supports oncogene-induced transformation.
Overall the manuscript seems technically sound and is well written. The regulation of oxidative stress in the context of oncogene-induced senescence is of significant interest and the involvement of the FoxM1 transcription factor provides a novel aspect. The identification of ROS detoxifying enzymes as transcriptional targets of FoxM1 is compelling and supports a role for FoxM1 in proliferating cells when FoxO transcription factors are inactive. One shortcoming of the study is that it mainly uses immortalised cell lines (either immortalised MEFs or IMR90 human embryonic fibroblasts). IMR90 cells have been shown to have high levels of p16 expression (Benanti et al., MCB 2004) . It would be intersting to see if oncogenic Ras induces FoxM1 expression also in primary MEFs. Also, the authors mainly rely on acidic beta galactosidase staining as an indicator of senescence. It would be useful to establish reduced proliferation in response to FoxM1 knockout or silencing in at least some of the cellular systems used here. Another problem is that the authors rely on a single siRNA sequence to show increased senescence and increased ROS levels following FoxM1 ablation throughout the paper. The experiments using FoxM1fl/fl MEFs confirm the importance of FoxM1 in Ras-induced transformation. However, the reduction in soft-agar growth seen is this experiment could be due to a role of FoxM1 in cell cycle progression. Despite these criticisms, the manuscript shows an interesting and novel role for FoxM1 linking ROS induction, proliferation and cell transformation.
Specific points:
There is no reference is given for the constitutively active FoxM1 mutant. 1C ). In addition, we have included control experiments and quantifications, as suggested by the reviewers. Also, we have included discussion on the studies that were pointed out by reviewer #2 citing the references. The Materials and Methods section has been expanded to include information suggested by the reviewers. A point-by-point response to the reviewers' comments is included below.
Referee #1:
The reviewer commented, "The link between ROS and upregulation of FoxM1 is unclear. The authors show that H2O2 upregulates FoxM1 and catalase blocks this, suggesting that hydrogen peroxide is important for gene induction. However, MnSOD mimetics (which generate hydrogen peroxide) inhibit the gene induction, while a MnSOD inhibitor induces FoxM1 gene induction. Isn't this contradictory? Which one of these reactive oxygen species is the important now? This needs to be clarified."
Response: We provided evidence that both superoxide and peroxide could activate expression of FoxM1. We have included a data showing that SOD-mimetics does not cause a significant accumulation of hydrogen peroxide (DCF fluorescence in supplementary Fig.1A ). Also, we included a statement to that effect in page 7 near the bottom. It is likely that the endogenous ROS scavengers, such as catalase, peroxiredoxins, and glutathione peroxidases quickly detoxified peroxide increased by Tempol treatment.
The reviewer commented, "In Fig. 1B and Suppl. Fig. 1B -why are TempoI and MnTM in absence of serum not shown?"
Response: Serum-starvation experiment has been included in Supplemental Fig. 1D .
The reviewer commented, "In Fig. 1 it is also unclear how cell were lysed for Western blotting. Were total cell lysates used? Is only cytosolic FoxM1 shown? Is the increase of FoxM1 also a result of translocation?"
Response: We used total cell lysates -That is now mentioned in page 24. We did not detect any change in localization of FoxM1.
The reviewer commented, "Supplementary Fig. 2: What is the mechanism of how FoxM1 blocks the H2O2-mediated activation of p38?"
Response: p38 is activated by ROS. Our observations suggest that over expression of FoxM1 increases expression of catalase, which inhibits the effective concentration of peroxides inside the cell, thereby attenuating the activation of p38. Also, see a new experiment in Fig. 3B showing addition of ROS scavengers inhibits the level of active p38 in FoxM1 knockdown cells. I have included a description along that line in page 11. The reviewer commented, "In Fig. 2B and Fig. 3 
: Can the siRNA effects be rescued by expression of FoxM1 (of another species)? This would be important to rule out off-target effects. Alternatively a second independent siRNA targeting FoxM1 could be used."
Response: Based on the reviewer's suggestion, we have included experiments (Fig. 2B, Fig. 3A , and supplementary Fig. 3A ) with two different FoxM1 siRNAs showing similar phenotype.
The reviewer commented, "Effects of the siRNA on other Fox transcription factors should be tested to rule out off-target effects."
Response: Based on the reviewer's suggestion, we have included western blots for FoxO and FoxA (Fig. 3A) to show FoxM1 siRNA specifically affects the level of FoxM1.
The reviewer commented, "In Fig. 2B, control blots for the knockdown of FoxM1 should be included."
Response: We have included western blot for FoxM1.
The reviewer commented, "Fig. 3B needs to include the inhibitors plus control siRNA to ensure that the effects seen are not unrelated.'
Response: We have included the inhibitor plus control siRNA experiment in Fig. 3B . Response: p38MAPK is known to be activated by various stresses, including oxidative stress and involved in premature senescence induced by those cellular stresses. We, therefore, hypothesized that p38MAPK activation observed from FoxM1-depleted cells is due to increased oxidative stress and subsequently increase cellular senescence. We have included new data in Fig. 3B showing that ROS scavengers, such as catalase or NAC reduce the level of active p38 observed in FoxM1-depleted cells, suggesting that p38 activation is indeed due to increased ROS levels. That is why addition of antioxidant, catalase, or p38-inhibitor reduces the level of senescence in FoxM1-depleted cells. We have included a statement clarifying that in page 11. Fig. 3D : We have included the experiment without H2O2 in Fig.3D .
The reviewer commented, "Fig. 4 should show Western blots for the antioxidant proteins."
Response: We have included the western blot in Fig. 4B . Response: We have revised the Materials and Methods section to address the concern raised by the reviewer. Also, the figure legends have been modified including the information as outlined below:
Reviewer: 1. Fig. 1D Response: Previous studies showed that FoxM1 ablation alone reduces cell proliferation (Wang et al. 2005 , Laoukili et al. 2005 . But, the contribution of ROS accumulation was not analyzed in those studies. The reviewer's point that the reduction of colony formations on soft agar could be due to reduced proliferation is valid, as it would be difficult to dissect FoxM1's role in stimulation of the proliferation genes and the ROS regulatory genes. We have included a statement along that line in page 10 (near the top, "Because ---"). But, ROS regulation by FoxM1 is also important for anchorage-independent growth of transformed cells, because intracellular ROS levels are known to play a critical role in cell detachment-induced cell death (anoikis) (Li et al., Circ. Res. 1999 ) and PRDX3, the ROS-regulatory gene, which we described in this paper as a FoxM1 target, also have been implicated in anchorage-independent growth (Wonsey et al. PNAS 2002) .
Reviewer: Figure 5: Does Akt-activation induce FoxM1 expression in IMR90 cells or immortalized MEFs?
Response: Activated Akt does not induce expression of FoxM1 because activated Akt, unlike activated Ras, fails to activate JNK, which is required for activation of FoxM1 by activated Ras. We have included these results in Supplementary Fig. 5 , and included a description along that line in page 15.
Reviewer: Figure Reviewer: Figure 6A : Proliferation should be quantified as well as induction of beta-gal activity.
Response: The quantifications for the cell-proliferation and BrdU -incorporation data have been included in Fig.6 .
Re-review 22 July 2009
The authors have significantly improved the manuscript and adequately answered most of the major criticisms. The only problems are the conclusions drawn from the experiments using cells expressing activated Akt. While the first part of the study demonstrates that Ras induces FOXM1 expression through the induction of ROS, the authors investigate the requirements of FOXM1 for transformation in IMR90 cells over-expressing activated Akt. Although these cells show increased levels of ROS as measured by DCF fluorescence, Akt does not induce expression of FOXM1. The authors conclude that this is due to the lack of JNK activation in response to Akt activation but do not offer a mechanistic explanation. It should also be considered that the FOXM1 addiction of Akt transformed cells could also require additional FOXM1 target genes not involved in detoxification of ROS.
However, I believe that the revised manuscript offers sufficient novel information to justify publication.
